We are creating some awesome events for you. Kindly bear with us.

Robot Industry Shines in China

The intelligent industry represented by robots is injecting new momentum into high-quality economic development and the global robot ecosystem is constantly improving in China. China also created an open platform to gather innovation resources, introduce new products and facilitate industrial cooperation. The robot industry needs to strengthen basic research and make technical breakthroughs to make more original innovations.

Secretary of China’s Leading Party Members Group called on to put enterprises at the dominant position of innovation and promote the integration of industries, universities and research agencies to better communicate science and create a sound social environment to boost the industry.

Chinese sci-tech and industrial communities should join hands with their global peers to develop intelligent industry and deepen innovative cooperation to make contributions to building a community with a shared future for mankind.

The robot industry is one of the major priorities in Beijing’s accelerating process to become an international sci-tech innovation centre.

– Mayor of Beijing

Beijing will give full play to its sci-tech advantages to provide support for the enterprises to carry out research, facilitate industrialisation and promote the coordinated development of robot enterprises with intelligent manufacturing.

The mayor of Beijing urged to gather all kinds of innovation elements to foster industrial champions and leading-position enterprises, establish joint platforms for innovation, cooperation and product test and verification, empower traditional industries with new modes and build highlands of robot innovation and application.

The Chinese government has attached great importance to boosting the high-quality development of the robot industry. The Ministry of Industry and Information Technology must implement the important instructions of the President of China and follow the deployment of the CPC Central Committee and the State Council to promote China’s robot industry from 4 perspectives: consolidating the industrial foundation, enhancing product supply, expanding application and optimising industrial ecology.

The exhibition displayed more than 500 new products from more than 110 enterprises and research agencies. The medical treatment robots and the application of brain-computer interface technologies highlighted the exhibition. Relevant experts, scholars and entrepreneurs both at home and abroad, together with representatives of international agencies participated in the event in a combination form of online and on-spot.

According to the International Federation of Robotics (IFR), China has had the most industrial robots in operation globally since 2016. By 2020, China is expected to produce 150,000 industrial robot units and have 950,300 industrial robots in operation.

China’s robotics industry is large, but still has significant room for development. The Chinese government has recognised as much in its Made in China 2025 (MIC 2025) industrial policy, which identifies the robotics industry as a strategically important sector. This designation creates both opportunities and challenges for foreign investors.

MIC 2025 starts by listing the robotics industry, along with artificial intelligence and automation, as one of the priority sectors for high-end development to push forward the transformation and upgrading of the manufacturing industry.

China has been utilising robots in various fields, including healthcare with the development of vascular interventional surgical robots. As reported by OpenGov Asia, Chinese researchers from the Beijing Institute of Technology have cooperated with Beijing Tiantan Hospital and other units to research core technology optimisation and special consumables of vascular interventional surgery robots. The surgery robot has become the interventional robot product with the fastest research and development progress in China.

With the support of the project of the National Key R&D Programme of China “Industrialisation Research and Application of Minimally Invasive Vascular Interventional Surgery Robot”, the development of the robot was fully completed. At present, the surgical robot, after further technological upgrades, has taken the lead in entering the clinical trial stage registered by the NMPA (National Medical Products Administration), and 123 clinical trial cases have been completed.

Send this to a friend